[1]Wang H, Yang H, Tracey KJ.Extracellular role of HMGB1 in in-flammation and sepsis[J].J Intern Med, 2004, 255 (3) :320-331.
|
[2]赵雷, 刘靖华, 唐靖, 等.人高迁移率族蛋白1的原核细胞表达及其功能研究[J].中国病理生理杂志, 2006, 22 (6) :1119-1123.
|
[3]王树彦, 陈宗祐.高迁移率族蛋白1与肿瘤[J].上海医学, 2009, 32 (8) :757-760.
|
[4] 中华医学会.慢性乙型肝炎防治指南[J].胃肠病学, 2006, 11 (9) :550-556.
|
[5]中华医学会.病毒性肝炎防冶方案[J].中华肝脏病杂志, 2000, 8 (3) :324-329.
|
[6]Ishak K, Baptista A, Bianchi L, et al.Histological grading andstaging of chronic hepatitis[J].J Hepatol, 1995, 22 (4) :696-699.
|
[7]Sappington PL, Yang R, Yang H, et al.HMGB l B box increasesthe permeability of Caco-2 enterocytic monolayers and impairs in-testinal barrier function in mice[J].Gastroenterology, 2002, 123 (4) :790-802.
|
[8]Sundberg E, Fasth AE, Palmblad K, et al.High mobility group boxchromosomal protein 1 act s as a proliferation signal for activated T lym-phocytes[J].Immunobiology, 2009, 214 (2) :303-309.
|
[9]Erlandsson Harris H, Andersson U.Mini review:The nuclear pro-tein HMGB l as a proinflammatory mediator[J].Eur J Immunol, 2004, 34 (6) :1503-1512.
|
[10]赵中夫, 韩德五.高迁移率族蛋白B-1及其在肝损伤合并内毒素血症中的作用[J].中华肝脏病杂志, 2006, 14 (9) :718-720.
|
[11]刘洪波, 范学工, 黄建军, 等.乙型肝炎患者血清高迁移率蛋白-1含量的检测及临床意义[J].中华肝脏病杂志, 2007, 15 (11) :812-815.
|
[12]刘洪波, 范学工, 刘悦晖, 等.肝损伤模型小鼠高迁移率族蛋白-1的表达[J].生命科学研究, 2008, 12 (2) :169-173.
|
[13]Müller S, Scaffidi P, Degryse B, et al.New EMBO members’re-view:the double life of HMGB1 chromatin protein:architecturalfactor and extracellular signal[J].EMBO J, 2001, 20 (16) :4337-4340.
|
[14]宋舟, 刘屹, 包国强, 等.HMGB1在大肠癌组织中的表达及意义[J].现代肿瘤医学, 2008, 16 (7) :1911-1194.
|
[15]Campana L, Bosurgi L, Rovere-Querini P.HMGB1:a two-headed signal regulating tumor progression and immunity[J].CurrOpin Immunol, 2008, 20 (3) :518-523.
|
[16]Cheng BQ, Jia CQ, Liu CT et al.Serum high mobility group boxchromosomal protein 1 is associated with clinicopathologic features inpatients with hepatocellular carcinoma[J].Dig Liver Dis, 2008, 40 (6) :446-452.
|
[17]Chung Hw, Lee SG, Kim H, et al.Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic featuresof gastric cancer[J].J Transl Med, 2009, 7 (1) :38.
|
[1] | Chenlu HAN, Haijun LIANG, Daokun YANG, Haiyan CHANG, Shuai WEI, Xingwei WANG, Haili GAO. Expression levels of serum high-mobility group box 1, soluble CD163, and prostaglandin E2 in patients with hepatitis B virus-related chronic-on-acute liver failure and their value in predicting prognosis[J]. Journal of Clinical Hepatology, 2024, 40(6): 1130-1135. doi: 10.12449/JCH240610 |
[2] | Chen Hao, Hao JianHeng, Li ZhenCheng, Xu HuiChao, Gao Yan, Miao YuChuan, Hao HuiQin, Liu Yang. Screening for differentially expressed genes in mice with autoimmune hepatitis and effect of saikosaponin-d on the expression of several differentially expressed genes[J]. Journal of Clinical Hepatology, 2020, 36(4): 840-846. doi: 10.3969/j.issn.1001-5256.2020.04.026 |
[3] | Tang Ling, Qiu LuDie, Qin Wen, Wu Gang. Expression of circular RNA FLI1 in patients with hepatocellular carcinoma and its association with prognosis[J]. Journal of Clinical Hepatology, 2019, 35(9): 1980-1984. doi: 10.3969/j.issn.1001-5256.2019.09.019 |
[4] | Fan Bin, Zhang Yong, Li JinMao, Liu Tao, Zhang JiaYao. Association between the expression of centromere protein F and prognosis in patients with hepatocellular carcinoma:An analysis using GEO database[J]. Journal of Clinical Hepatology, 2018, 34(7): 1475-1480. doi: 10.3969/j.issn.1001-5256.2018.07.022 |
[5] | Yang XinYing, Kang FuBiao, Ye LiHong, Dai ErHei, Sun DianXing. Level of high-mobility group box 1 in patients with chronic hepatitis B and liver cirrhosis and its clinical significance[J]. Journal of Clinical Hepatology, 2018, 34(9): 1901-1904. doi: 10.3969/j.issn.1001-5256.2018.09.015 |
[6] | Xiao ChunYang, Li QinKai, Yu JingXia, Liu Ting, Lu LunGen, Xu MingYi. Risk genes for the development of chronic hepatitis B cirrhosis assessed by prediction analysis of microarrays[J]. Journal of Clinical Hepatology, 2016, 32(7): 1323-1329. doi: 10.3969/j.issn.1001-5256.2016.07.022 |
[7] | Zhang JiCai, Yu ZongTao, Lyu Jun, Li HaiPing, Gao Bo. Relationship between HBV infection and DNMT expression in liver cancer tissues[J]. Journal of Clinical Hepatology, 2013, 29(8): 620-623. doi: 10.3969/j.issn.1001-5256.2013.08.017 |
[8] | Ye Chao, Chen YongPing, Dai ZhiJuan, Li WenYuan, Lin Zhuo, Cheng Yuan, Jin XiaoZhi. Dynamic expression of β-catenin in rat models of hepatic fibrosis and its significance[J]. Journal of Clinical Hepatology, 2011, 27(3): 261-264. |
[9] | Liu QiSheng, Xu XiaoHong, Liu Huai. Expression of Plk1 and Survivin in hepatocellular carcinoma and its significance[J]. Journal of Clinical Hepatology, 2011, 27(4): 397-399. |
[10] | Gao BaoHua, Liu Bing, Zheng JianYun, Wu FangXiong, Wang Wen, Li Lei, Niu ChunYan. The study of the expression of COX-2 and CDKN2A in chronic hepatitis B and liver cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 273-276. |
[11] | Li HaiPing, Tao JianShu, Gao Bo, Yu ZongTao, Li WenCui, Zhang JiCai. The expression and clinical significance of resistance gene in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(9): 972-975. |
[12] | Niu ChunYan, Zheng JianYun, Li Lei, Gao BaoHua, Liu Bing, Luo JianMei. The expression and significance of HMGB1 in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(8): 807-809. |
[13] | Zhang Zhe, Guo JinSheng. The role of high mobility group box 1 in human liver diseases[J]. Journal of Clinical Hepatology, 2011, 27(10): 1116-1120. |
[14] | Chen LiDong, Cheng Jun, Hong Yuan, Zhang LianFeng, Han Li, Guo Jiang. Construction of the prokaryotic expression vector of NS5ATP4A gene and its expression[J]. Journal of Clinical Hepatology, 2010, 26(4): 371-373. |
[15] | Cheng LiangBin, Cheng Ming, Liu Yan. The effect of Kangxian ruangan granule on the expression of nuclear factor-κB gene in fibrotic rat liver[J]. Journal of Clinical Hepatology, 2010, 26(4): 410-412. |
[16] | Wu ShiPin, Liu ZhenZhen, Zhou Jun, Huang MingHui. Analysis of differential gene expression profiles in hepatic fibrosis tissue using cDNA microarray[J]. Journal of Clinical Hepatology, 2007, 23(4): 258-260. |
[18] | Lu DongDong, Zhang XiRan. The primary study of expression and function of CK2α subunit in liver cancer[J]. Journal of Clinical Hepatology, 2003, 19(4): 240-241. |
[19] | Wang AiMin, Wang BaoEn, Yang YueWei, Zhang Bin, Jiang LongAn, Du ShuangCun. Interstitial collagenase gene expression in patients with chronic liver disease[J]. Journal of Clinical Hepatology, 2000, 16(2): 90-91+124. |